Growth Metrics

Masimo (MASI) Net Income - Minority (2012 - 2021)

Masimo's quarterly Net Income - Minority came in at $20000.0 in Q1 2021, up 106.73% quarter-over-quarter from -$297000.0 in Q1 2016.

Masimo has reported Net Income - Minority for 6 years, with the latest figure at $20000.0 in Q1 2021.

  • For the quarter ending Q1 2021, Net Income - Minority changed N/A year-over-year to $20000.0; the trailing twelve-month figure through Jan 2021 stood at $20000.0 (changed N/A YoY), and the FY2021 full-year result was $20000.0, changed N/A from the prior year.
  • Net Income - Minority for Q1 2021 stood at $20000.0, up from -$297000.0 in the prior quarter.
  • The five-year high for Net Income - Minority was $20000.0 in Q1 2021, with the low at $20000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -13.34 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn -

Historic Data

Download Data 🔒
DateValue
Jan 2, 2021 20,000.00
Jan 2, 2016 -297,000.00
Oct 3, 2015 1.00 Mn
Jul 4, 2015 -392,000.00
Apr 4, 2015 -1.05 Mn
Jan 3, 2015 -1.74 Mn
Sep 27, 2014 -1.18 Mn
Jun 28, 2014 96,000.00
Mar 29, 2014 96,000.00
Dec 28, 2013 68,000.00
Dec 29, 2012 -2.59 Mn